Get the Ricochet app

Ricochet will work fine in a browser on your mobile devices, but for the best experience please download our app.

Download on the App StoreGet it on Google Play

Become a member.

Tired of the toxicity of social media? Why not join Ricochet for just $5/month? Think of it as an online bar. Come in, have a drink, hang out, say whatever you want. But don’t badger, bully, or berate the other drinkers. That's our only rule.

Innovation Reduction Act: Price Controls’ Prescription for New Therapies

Subscribe to HubwonkSubscribe

Joe Selvaggi talks with Pioneer Institute’s Senior Fellow Dr. Bill Smith about the changes to drug pricing laws included in the recently passed Inflation Reduction Act. They discuss the legislation's provisions, and who wins and loses as drug companies announce their response to the new law.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the

Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Host:
Joe Selvaggi
Guest:
WSWilliam Smith